vs
Exodus Movement, Inc.（EXOD）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Exodus Movement, Inc.的1.2倍（$35.5M vs $29.4M），Exodus Movement, Inc.净利率更高（-181.0% vs -304.2%，领先123.2%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -34.4%），Exodus Movement, Inc.自由现金流更多（$-25.8M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 0.6%）
Exodus Movement成立于2015年，核心产品Exodus加密货币钱包支持多端使用，可在桌面端Windows、macOS、Linux系统，移动端iOS、安卓系统以及浏览器扩展中使用，支持比特币、以太坊、索拉纳等多种主流数字资产的存储管理。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
EXOD vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $29.4M | $35.5M |
| 净利润 | $-53.2M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -226.9% | -304.8% |
| 净利率 | -181.0% | -304.2% |
| 营收同比 | -34.4% | 681.7% |
| 净利润同比 | -179.5% | 39.6% |
| 每股收益（稀释后） | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $29.4M | $35.5M | ||
| Q3 25 | $30.3M | $5.2M | ||
| Q2 25 | $25.8M | $19.2M | ||
| Q1 25 | $36.0M | $14.7M | ||
| Q4 24 | $44.8M | $4.5M | ||
| Q3 24 | $20.1M | $26.1M | ||
| Q2 24 | $22.3M | $14.4M | ||
| Q1 24 | $29.1M | $13.8M |
| Q4 25 | $-53.2M | $-108.1M | ||
| Q3 25 | $17.0M | $-162.3M | ||
| Q2 25 | $37.7M | $-171.9M | ||
| Q1 25 | $-12.9M | $-202.5M | ||
| Q4 24 | $66.9M | $-178.9M | ||
| Q3 24 | $843.0K | $-95.8M | ||
| Q2 24 | $-9.6M | $-97.5M | ||
| Q1 24 | $54.8M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | 43.7% | 53.7% | ||
| Q2 24 | 51.7% | 36.2% | ||
| Q1 24 | 63.2% | 19.1% |
| Q4 25 | -226.9% | -304.8% | ||
| Q3 25 | 66.9% | -3327.6% | ||
| Q2 25 | — | -916.8% | ||
| Q1 25 | -60.4% | -1297.9% | ||
| Q4 24 | — | -4042.4% | ||
| Q3 24 | -0.3% | -377.1% | ||
| Q2 24 | -66.1% | -697.4% | ||
| Q1 24 | — | -698.4% |
| Q4 25 | -181.0% | -304.2% | ||
| Q3 25 | 56.2% | -3135.3% | ||
| Q2 25 | 145.8% | -894.2% | ||
| Q1 25 | -35.8% | -1373.3% | ||
| Q4 24 | 149.4% | -3935.5% | ||
| Q3 24 | 4.2% | -367.5% | ||
| Q2 24 | -43.1% | -676.6% | ||
| Q1 24 | 188.5% | -662.4% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | — | $-0.41 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | — | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.9M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $247.4M | $1.1B |
| 总资产 | $266.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $4.9M | $743.3M | ||
| Q3 25 | $50.5M | $659.8M | ||
| Q2 25 | $52.9M | $525.1M | ||
| Q1 25 | $59.8M | $500.5M | ||
| Q4 24 | $37.9M | $594.4M | ||
| Q3 24 | $26.5M | $427.6M | ||
| Q2 24 | $27.8M | $474.3M | ||
| Q1 24 | $21.0M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $247.4M | $1.1B | ||
| Q3 25 | $296.7M | $1.0B | ||
| Q2 25 | $277.1M | $919.1M | ||
| Q1 25 | $241.5M | $933.9M | ||
| Q4 24 | $257.5M | $1.0B | ||
| Q3 24 | $191.2M | $524.6M | ||
| Q2 24 | $190.8M | $584.4M | ||
| Q1 24 | $199.1M | $401.2M |
| Q4 25 | $266.8M | $1.5B | ||
| Q3 25 | $338.5M | $1.4B | ||
| Q2 25 | $313.7M | $1.3B | ||
| Q1 25 | $263.2M | $1.3B | ||
| Q4 24 | $288.0M | $1.4B | ||
| Q3 24 | $211.6M | $726.5M | ||
| Q2 24 | $211.6M | $775.9M | ||
| Q1 24 | $225.4M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-25.6M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-25.8M | $-47.3M |
| 自由现金流率自由现金流/营收 | -87.9% | -133.1% |
| 资本支出强度资本支出/营收 | 0.9% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-42.3M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-25.6M | $-46.1M | ||
| Q3 25 | $-4.8M | $-117.4M | ||
| Q2 25 | $-5.3M | $-76.4M | ||
| Q1 25 | $-6.2M | $-132.0M | ||
| Q4 24 | $-12.0M | $-115.4M | ||
| Q3 24 | $-4.9M | $-59.2M | ||
| Q2 24 | $-2.4M | $-82.2M | ||
| Q1 24 | $450.0K | $-102.3M |
| Q4 25 | $-25.8M | $-47.3M | ||
| Q3 25 | $-4.8M | $-117.6M | ||
| Q2 25 | $-5.4M | $-79.6M | ||
| Q1 25 | $-6.2M | $-133.8M | ||
| Q4 24 | $-12.3M | $-116.7M | ||
| Q3 24 | $-4.9M | $-63.8M | ||
| Q2 24 | $-2.4M | $-83.4M | ||
| Q1 24 | $300.0K | $-109.0M |
| Q4 25 | -87.9% | -133.1% | ||
| Q3 25 | -16.0% | -2272.5% | ||
| Q2 25 | -20.7% | -413.9% | ||
| Q1 25 | -17.3% | -907.4% | ||
| Q4 24 | -27.5% | -2567.7% | ||
| Q3 24 | -24.5% | -244.6% | ||
| Q2 24 | -10.8% | -578.5% | ||
| Q1 24 | 1.0% | -789.9% |
| Q4 25 | 0.9% | 3.5% | ||
| Q3 25 | 0.1% | 4.7% | ||
| Q2 25 | 0.4% | 16.4% | ||
| Q1 25 | 0.1% | 12.4% | ||
| Q4 24 | 0.6% | 28.6% | ||
| Q3 24 | 0.2% | 17.5% | ||
| Q2 24 | 0.2% | 8.2% | ||
| Q1 24 | 0.5% | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | -0.28× | — | ||
| Q2 25 | -0.14× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.18× | — | ||
| Q3 24 | -5.80× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXOD
| Exchange Aggregation | $26.6M | 90% |
| Other | $2.8M | 10% |
RXRX
暂无分部数据
